文献速递艾滋病与性传播感染

细胞介导免疫靶向持续存在的HIV病毒库

Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus Reservoir.
PubMed 文献 · J Infect Dis · 2017-01-01

综述探讨通过细胞介导免疫策略实现HIV治愈的路径,聚焦于在稳定抑制的ART治疗受试者中,如何通过序贯激活重建的免疫系统并递送最佳T细胞应答来最大化靶点识别与清除。作者认为联合免疫策略优于单一策略,已有初步人体试验数据支持先天与工程化T细胞应答联合以最大化抗病毒压力。

要点

  • 优化细胞介导免疫需解决表位逃逸与效应记忆应答不持久两大障碍。
  • 联合先天免疫与工程化T细胞应答可最大化抗病毒压力,助力HIV缓解或治愈。
  • 已有初步人体试验数据支持联合免疫策略的可行性。

核心结论

  • 联合多种免疫策略是细胞介导控制与清除HIV的更优路径。

研究设计与样本

  • 综述,聚焦稳定抑制的ART治疗受试者中利用细胞介导免疫控制HIV的治愈策略。

主要发现

  • 自然诱导的细胞介导免疫应答很少能根除HIV感染。
  • 需解决表位逃逸和缺乏持续效应记忆应答的问题方可优化免疫应答。
  • 联合先天与工程化T细胞应答可最大化抗病毒压力,已有初步人体试验数据支持。

临床怎么用

  • 在稳定抑制的ART治疗受试者中,可考虑联合免疫策略以最大化靶点识别与清除。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Effective clearance of virally infected cells requires the sequential activity of innate and adaptive immunity effectors. In human immunodeficiency virus (HIV) infection, naturally induced cell-mediated immune responses rarely eradicate infection. However, optimized immune responses could potentially be leveraged in HIV cure efforts if epitope escape and lack of sustained effector memory responses were to be addressed. Here we review leading HIV cure strategies that harness cell-mediated control against HIV in stably suppressed antiretroviral-treated subjects. We focus on strategies that may maximize target recognition and eradication by the sequential activation of a reconstituted immune system, together with delivery of optimal T-cell responses that can eliminate the reservoir and serve as means to maintain control of HIV spread in the absence of antiretroviral therapy (ART). As evidenced by the evolution of ART, we argue that a combination of immune-based strategies will be a superior path to cell-mediated HIV control and eradication. Available data from several human pilot trials already identify target strategies that may maximize antiviral pressure by joining innate and engineered T cell responses toward testing for sustained HIV remission and/or cure.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Riley JL, Montaner LJ. Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus Reservoir. J Infect Dis. 2017. PMID: 28520969. doi:10.1093/infdis/jix002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。